Mei‐Due Yang

453 citations
32 papers · 353 indexed · h-index 12
Topics
Protease and Inhibitor Mechanisms (4 papers)Cancer, Hypoxia, and Metabolism (3 papers)Cancer, Lipids, and Metabolism (3 papers)
Partner nations
TaiwanChinaUnited States

In The Last Decade

Mei‐Due Yang

31 papers receiving 348 citations

Peers

Mei‐Due Yang
Comparison fields: 5 of 75
  • Molecular Biology 144
  • Cancer Research 102
  • Pharmacology 61
  • Oncology 58
  • Surgery 40
Replace Jalahalli M. Siddesha with:
Jalahalli M. Siddesha United States
Suneetha Amara United States
Zhigang Luo China
Yukai Xiang China
Jianguo Xie China
Andrew Harbottle United Kingdom
Lixia Ji China
Sima Mansoori Derakhshan Iran
In Sang Song South Korea
Qingchun Diao China
Mei‐Due Yang relative to Jalahalli M. Siddesha United States Jalahalli M. Siddesha's profile →
Citations per field
00.5×2.5×
Jalahalli M. Siddesha · 1×
Citations per year

Countries citing papers authored by Mei‐Due Yang

Since Specialization
Citations

This map shows the geographic impact of Mei‐Due Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mei‐Due Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mei‐Due Yang more than expected).

Fields of papers citing papers by Mei‐Due Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mei‐Due Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mei‐Due Yang. The network helps show where Mei‐Due Yang may publish in the future.

Co-authorship network of co-authors of Mei‐Due Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Mei‐Due Yang. A scholar is included among the top collaborators of Mei‐Due Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mei‐Due Yang. Mei‐Due Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 2
3 7
4 3
5 9
6 7
7 9
8 10
9 6
10 8
11 11
12 10
13 13
14 0
15 13
16 3
17 14
18 18
19 27
20
Incarcerated obturator hernia
1

About Mei‐Due Yang

Mei‐Due Yang is a scholar working on Cancer Research, Behavioral Neuroscience and Biochemistry, having authored 32 papers that have together received 353 indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (4 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Cancer, Lipids, and Metabolism (3 papers). The work is most often cited by research in Cancer Research (102 citations), Drug Discovery (1 citation) and Pharmacology (39 citations). Mei‐Due Yang has collaborated with scholars based in Taiwan, China and United States. Frequent co-authors include Jing‐Gung Chung, DA-TIAN BAU, Jai‐Sing Yang, Kung‐Wen Lu, WEN-SHIN CHANG, Jing‐Pin Lin, Chin‐Cheng Su, Yin‐Ching Chan, Yao‐Ching Hung and Wei‐Chung Cheng. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026